Insider · CIK 0001351095
Kirk Wheeler Michel
Files at PBSV (Pharma-Bio Serv, Inc.). First filing -, latest -.
In brief
Kirk Wheeler Michel files SEC Form 4 as chair and director at PBSV (Pharma-Bio Serv, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kirk Wheeler Michel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 10, 2026 | PBSV Pharma-Bio Serv, Inc. | AGrant or award Stock Optionderivative | +20,000 | $0.00 | $0 | 20,000 | Jan 14, 2026 |
| Jan 10, 2024 | PBSV Pharma-Bio Serv, Inc. | AGrant or award Stock Optionderivative | +20,000 | $0.00 | $0 | 20,000 | Jan 12, 2024 |
| Jan 5, 2024 | PBSV Pharma-Bio Serv, Inc. | MOption exercise Common Stock | +20,000 | $0.76 | $15k | 57,942 | Jan 9, 2024 |
| Jan 5, 2024 | PBSV Pharma-Bio Serv, Inc. | FTax withholding Common Stock | -14,340 | $1.06 | $15k | 43,602 | Jan 9, 2024 |
| Jan 5, 2024 | PBSV Pharma-Bio Serv, Inc. | MOption exercise Stock Optionderivative | -20,000 | $0.00 | $0 | 0 | Jan 9, 2024 |
Questions about Kirk Wheeler Michel
Answered from the filings on this page, as of the latest one.
Is Kirk Wheeler Michel buying or selling?
Kirk Wheeler Michel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kirk Wheeler Michel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kirk Wheeler Michel has 0.
Where does Kirk Wheeler Michel file Form 4?
Kirk Wheeler Michel has filed Form 4 at PBSV (Pharma-Bio Serv, Inc.) as Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.